GlassScriptPhysician profile
Thomas P Morrissey
NPI 1720058571
$6,155.28
in general payments reported to CMS, 2019-2025
9 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 78% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2022: $211 · 2023: $354 · 2024: $3,540 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,700 · Food and Beverage: $1,100 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,700.00 |
| Food and Beverage | $1,100.49 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,272.39 | 2024-2025 | Jemperli |
| Abbvie INC. | $1,800.00 | 2025 | |
| Seagen INC. | $246.86 | 2022-2023 | Tivdak |
| Intuitive Surgical, INC. | $228.45 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $127.54 | 2024 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Eisai INC. | $123.19 | 2024 | |
| Immunogen, INC. | $116.32 | 2023 | Elahere |
| Coopersurgical, INC. | $115.53 | 2023 | Summit Doppler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Morrissey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.